Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    "methodist hospital" | Open Studies | "Sclerosis" | United States, Texas | Houston
Show Display Options
Rank Status Study
1 Recruiting Imaging and BioFluid Biomarkers in Amyotrophic Lateral Sclerosis
Condition: Amyotrophic Lateral Sclerosis (ALS)
Intervention: Drug: [18F] GE-180
2 Recruiting Dysport® Treatment of Urinary Incontinence in Adults Subjects With Neurogenic Detrusor Overactivity (NDO) Due to Spinal Cord Injury or Multiple Sclerosis - Study 1
Conditions: Urinary Incontinence;   Overactive Bladder
Interventions: Drug: AbobotulinumtoxinA;   Drug: AbobotulinumtoxinA Placebo

Study has passed its completion date and status has not been verified in more than two years.